Program for Anxiety and Affective disorders, Stockholm Southwest Psychiatry
Stockholm, 141 86, Sweden
NCT Number: NCT05379244
Between 50-80 percent of patients in psychiatry have insomnia-type sleep problems. In addition to reduced quality of life and impaired function, sleep problems can aggravate other psychiatric problems and increase the risk of relapse into, for example, depression. According to international guidelines, cognitive behavioral therapy for insomnia (CBT-i) should be used as the first choice for treatment of insomnia. In practice, however, it is very uncommon for psychiatric patients to be offered CBT-i, instead most are treated with sleep medications. There is also a lack of research studies evaluating CBT-i in regular clinical practice.
This pilot study investigated the feasibility of a group treatment with CBT-i at a psychiatric outpatient clinic in Stockholm for patients with depression, bipolar disorder II, anxiety syndrome and PTSD. Changes in symptoms of insomnia, depression, and anxiety after treatment were also investigated.
Patients with self-perceived sleep problems were offered a six-session group treatment based on CBT-i. The primary outcome was clinical feasibility, defined as: the influx of patients sufficient to start at least one group per semester (at least 8 patients); at least half of included patients participate in the first session; patients participate in at least half of the sessions; less than half of the patients drop out of treatment; group leaders find the treatment manual credible, easy to use and want to continue working with it after the study is completed.
Secondary outcomes were changes in insomnia symptoms, and changes in symptoms of depression and anxiety.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Stockholm, 141 86, Sweden
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Behavioral intervention based on Cognitive Behavioral Therapy for insomnia, adjusted for psychiatric patients with anxiety disorders, affective disorders and trauma
Time frame: Screening
Influx of patients should be sufficient to start at least one group per semester (at least 8 patients)
Time frame: First session (1 week)
At least half of included patients should attend the first treatment session
Time frame: Post-treatment (6 weeks)
Average number of sessions attended should be no less than 3
Time frame: Post-treatment (6 weeks)
Less than half of the patients should drop out of treatment
Time frame: Post-treatment (6 weeks)
Group leaders should find the treatment manual credible and easy to use, and be willing to continue using the treatment manual after the study is completed
Time frame: Post-treatment (6 weeks), Three-month follow-up (21 weeks)
7-item self-reported measure of insomnia severity, 0-28 points, lower is better.
Time frame: Post-treatment (6 weeks), Three-month follow-up (21 weeks)
9-item depression inventory, 0-27 points, lower is better
Time frame: Post-treatment (6 weeks), Three-month follow-up (21 weeks)
7-item anxiety inventory, 0-21 points, lower is better
Karolinska Institutet
Other
Better Sleep in Psychiatric Care - Clinical Feasibility and Preliminary Effects of CBT for Insomnia in a Mixed Psychiatric Sample at an Outpatient Clinic
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06282146
Anxiety Disorders, Behavior
Boston, Massachusetts, United States
View Trial DetailsNCT05228964
Anxiety Disorders, Behavior
Austin, Texas, United States
View Trial DetailsNCT07137572
Adjustment Disorder, Adjustment Disorders
Athens, Greece
View Trial DetailsNCT05294848
Anxiety Disorders, Behavior
Tel Aviv, Israel
View Trial Details